Lu Hongbo
Director
3 companies
Insider Signal Score
59
GoodTrades Analyzed
11
12M Win Rate
50.0%
Avg 3M Return
-1.2%
Avg 12M Return
+2.3%
Lu Hongbo is a Director at Terns Pharmaceuticals, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 13 buys and 0 sells.
Estimated insider holdings value: $36.4M based on current market prices.
Holdings by Company
Transaction History
Showing 7 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | ZBIO Zenas Biopharma, Inc. | Director | Buy | 321,983 | $18.63 | $6,000,031.00 | +547.4% | -20.3% | - | |
| Sep 13, 2024 | ZBIO Zenas Biopharma, Inc. | Director | Buy | 58,823 | $17.00 | $999,991.00 | New | -49.0% | +11.5% | |
| Sep 12, 2024 | TERN Terns Pharmaceuticals, Inc. | Director | Buy | 476,190 | $10.50 | $4,999,995.00 | +250.0% | -29.5% | -24.0% | |
| Mar 20, 2024 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Buy | 3,000 | $27.66 | $82,990.00 | +3.2% | -16.3% | -46.3% | |
| Dec 23, 2022 | TERN Terns Pharmaceuticals, Inc. | Director | Buy | 758,620 | $7.25 | $5,499,995.00 | +21.2% | +10.3% | -20.5% | |
| Sep 7, 2022 | TERN Terns Pharmaceuticals, Inc. | Director | Buy | 600,000 | $3.60 | $2,160,000.00 | +20.1% | +54.2% | +37.6% | |
| Aug 16, 2022 | TERN Terns Pharmaceuticals, Inc. | Director | Buy | 2,624,239 | $2.66 | $6,980,244.40 | +79.1% | -7.2% | +14.3% |